Skip to main content
. 2021 Feb 5;17(2):e1008982. doi: 10.1371/journal.ppat.1008982

Fig 6. Effect of the antagonists: dihydro-β-erythroidine (DHβE) and derquantel (der) on Tsu-ACR-16-like receptor mediated 100 μM ACh current response.

Fig 6

Results are given as normalized mean ± SEM inhibition of the initial current response of 100 μM ACh. DHβE produced an almost insignificant block of the Tsu-ACR-16-like receptor mediated ACh response (i.e. 7.60 ± 1.61%) and no effect was observed for der (0.16 ± 1.61%).